Drug development is difficult at the best of times, but it's significantly more difficult when dealing with rare disorders. The average cost of producing a new medicine has been a point of conflict, with estimates varying from $314 million to $2.8 billion in recent years. This make it more important to identify the best opportunities before investment of time and money. Disease and Market Landscape can help the companies to make smart choice and prepare a roadmap for the future strategies.
The major question can be answered by these exercises:
To identify the attractive indications from the disease universe
- Level of pipeline activity
- Level of opportunity
- Epidemiology
- Addressable patient size
- Available treatment options
- Unmet needs
- Licensing opportunities
What Process we Follow ?
- Opportunity assessments based on epidemiological forecasting
- Incidence
- Prevalence
- Cost of Therapy
- Therapy Pricing
- Create a Disease Landscape
- Various Treatment Algorithm
- Create a list of pipeline assets
- List of competitors
- Create a list of indications
- Shortlist attractive indications
Finalization of selected indications from clinical and commercial perspective
Work with DSIP Global
Reliable, methodical and delivered to a standard you can put in front of your client.
Start a Project →